Market
Lanes are never summed. Equity is Form D filings and matched press rounds; awards and exits will have their own sources.
Health & bio: subsectors
6 subsectors, sized by amount sold · 90 days to 2026-10-04 · as of 2026-10-0416 rounds not yet in a sector
16 rounds not yet in a sector
- ▲ Rising
- Steady
- Leaning (80%)
- ▼ Falling
- Quiet
Coloured by subsector state, 28 days to 2026-10-03 vs prior 28; shaded when the change is clear at 90% confidence, palest when only at 80%.
Equity · amount sold
Capital by week
Dollars sold per filing week, round count under each bar · 4 weeks to 2026-10-04 · as of 2026-10-04Stage mix
Inferred stage · 90 days to 2026-10-04 · as of 2026-10-04- Pre-seed123 roundsPre-seed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $157MAmount sold in original Pre-seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Seed383 roundsSeed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.2BAmount sold in original Seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series A287 roundsSeries A rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.7BAmount sold in original Series A filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series B88 roundsSeries B rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.5BAmount sold in original Series B filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series C+84 roundsSeries C+ rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $28.8BAmount sold in original Series C+ filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Stage not inferred7 roundsStage not inferred rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.0BAmount sold in original Stage not inferred filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
Bar length is each stage’s share of the window’s rounds. Dollars of original filings only: an amendment’s restated amount counts in the map, not here. Stage is inferred from the amount sold, never stated on Form D; a stage named in a press release wins.
Where it landed
Which states the money was raised from, by the company's HQ · 90 days to 2026-10-04 · as of 2026-10-04- $0+
- $353M+
- $1.4B+
- $3.2B+
- $5.7B+
Mega-rounds shown separately (see the band above)
Rounds
Newest first · every row traces to a Form D on EDGAR or a matched press release · as of 2026-10-04| Company | Sector | Stage | Sold of offered | Filed | HQ | Exemption | Open roles | Hiring | Flags | |
|---|---|---|---|---|---|---|---|---|---|---|
| CarebilityQuiet$8.8M of $8.8M · Series A · Health & bio · 506(b) · Richardson, TX · 2026-10-02NewAI-native | CarebilityNewAI-native | Health & bio | Series A | $8.8M of $8.8MAmount sold of the amount offered on the filing of 2026-10-02 · as of 2026-10-04How this is computed → | 2026-10-02 | Richardson, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | NewAI-native |
| Solaris EndovascularQuiet$5.0M of $10.0M · Seed · Health & bio · 506(b) · Dallas, TX · 2026-10-01NewUndersubscribed | Solaris EndovascularNewUndersubscribed | Health & bio | Seed | $5.0M of $10.0MAmount sold of the amount offered on the filing of 2026-10-01 · as of 2026-10-04How this is computed → | 2026-10-01 | Dallas, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | NewUndersubscribed |
| DozeeQuiet$10.0M of $10.0M · Series A · Health & bio · 506(b) · Houston, TX · 2026-08-24 | Dozee | Health & bio | Series A | $10.0M of $10.0MAmount sold of the amount offered on the filing of 2026-08-24 · as of 2026-10-04How this is computed → | 2026-08-24 | Houston, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| BioGene TherapeuticsQuiet$3.0M of $3.0M · Seed · Health & bio · 506(b) · Austin, TX · 2026-08-07 | BioGene Therapeutics | Health & bio | Seed | $3.0M of $3.0MAmount sold of the amount offered on the filing of 2026-08-07 · as of 2026-10-04How this is computed → | 2026-08-07 | Austin, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| BioGene Therapeutics: $3.0M of $3.0M · Seed · Health & bio · 506(b) · Austin, TX · 2026-08-06 | BioGene Therapeutics | Health & bio | Seed | $3.0M of $3.0MAmount sold of the amount offered on the filing of 2026-08-06 · as of 2026-10-04How this is computed → | 2026-08-06 | Austin, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| BioGene Therapeutics: $4.5M of $4.5M · Seed · Health & bio · 506(b) · Austin, TX · 2026-07-23 | BioGene Therapeutics | Health & bio | Seed | $4.5M of $4.5MAmount sold of the amount offered on the filing of 2026-07-23 · as of 2026-10-04How this is computed → | 2026-07-23 | Austin, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| SimbryoHiring actively$5.3M of $5.3M · Seed · Health & bio · 506(b) · Houston, TX · 2026-07-27 | Simbryo | Health & bio | Seed | $5.3M of $5.3MAmount sold of the amount offered on the filing of 2026-07-27 · as of 2026-10-04How this is computed → | 2026-07-27 | Houston, TX | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Asher HealthQuiet$3.0M of $3.0M · Seed · Health & bio · 506(b) · Plano, TX · 2026-07-27 | Asher Health | Health & bio | Seed | $3.0M of $3.0MAmount sold of the amount offered on the filing of 2026-07-27 · as of 2026-10-04How this is computed → | 2026-07-27 | Plano, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Brius Technologies (Brava)Quiet$5.0M of $15.6M · Seed · Health & bio · 506(b) · Addison, TX · 2026-07-23Undersubscribed | Brius Technologies (Brava)Undersubscribed | Health & bio | Seed | $5.0M of $15.6MAmount sold of the amount offered on the filing of 2026-07-23 · as of 2026-10-04How this is computed → | 2026-07-23 | Addison, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | Undersubscribed |
| TYBR HealthQuiet$14.4M of $30.0M · Series A · Health & bio · 506(b) · Houston, TX · 2026-07-22 | TYBR Health | Health & bio | Series A | $14.4M of $30.0MAmount sold of the amount offered on the filing of 2026-07-22 · as of 2026-10-04How this is computed → | 2026-07-22 | Houston, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Skybound MedtechQuiet$1.3M of $1.3M · Pre-seed · Health & bio · 506(b) · Houston, TX · 2026-07-09 | Skybound Medtech | Health & bio | Pre-seed | $1.3M of $1.3MAmount sold of the amount offered on the filing of 2026-07-09 · as of 2026-10-04How this is computed → | 2026-07-09 | Houston, TX | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet |